Nonoperating Income (Expense) of Caris Life Sciences, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Caris Life Sciences, Inc. annual and quarterly Nonoperating Income (Expense) in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Caris Life Sciences, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $8,317,000, a 21% decline year-over-year.
  • Caris Life Sciences, Inc. annual Nonoperating Income (Expense) for 2025 was $113,201,000, a 357% decline from 2024.
  • Caris Life Sciences, Inc. annual Nonoperating Income (Expense) for 2024 was $24,768,000, a 13% decline from 2023.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)

Caris Life Sciences, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $113,201,000 -$88,433,000 -357% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 $24,768,000 -$2,904,000 -13% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 $21,864,000 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2026 2025 FY

Caris Life Sciences, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,317,000 -$1,430,000 -21% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $53,801,000 -$54,626,000 -6621% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q3 2024 $6,887,000 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $825,000 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.